278 related articles for article (PubMed ID: 26130472)
1. Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.
Caiado J; Castells M
Curr Allergy Asthma Rep; 2015 Apr; 15(4):15. PubMed ID: 26130472
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.
Caiado J; Picard M
Curr Allergy Asthma Rep; 2014 Aug; 14(8):451. PubMed ID: 24951237
[TBL] [Abstract][Full Text] [Related]
3. Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.
Giavina-Bianchi P; Galvão VR; Picard M; Caiado J; Castells MC
J Allergy Clin Immunol Pract; 2017; 5(3):728-736. PubMed ID: 28034549
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy.
Caiado J; Venemalm L; Pereira-Santos MC; Costa L; Barbosa MP; Castells M
J Allergy Clin Immunol Pract; 2013; 1(5):494-500. PubMed ID: 24565621
[TBL] [Abstract][Full Text] [Related]
5. Low Cross-Reactivity Between Cisplatin and Other Platinum Salts.
Pasteur J; Favier L; Pernot C; Guerriaud M; Bernigaud C; Lepage C; Jouve JL; Isambert N; Collet E
J Allergy Clin Immunol Pract; 2019; 7(6):1894-1900. PubMed ID: 30776524
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
[TBL] [Abstract][Full Text] [Related]
7. Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds.
Pedraza-Nieto L; Beunza-Sola M; Rodríguez CA; Moreno E; Otero MJ
Int J Clin Pharm; 2021 Aug; 43(4):1123-1127. PubMed ID: 33937971
[TBL] [Abstract][Full Text] [Related]
8. Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
Otani IM; Wong J; Banerji A
Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
10. [Platinum salts hypersensitivity].
Couraud S; Planus C; Rioufol C; Mornex F
Rev Pneumol Clin; 2008 Feb; 64(1):20-6. PubMed ID: 18603175
[TBL] [Abstract][Full Text] [Related]
11. Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service.
Capelle H; Tummino C; Greillier L; Gouitaa M; Birnbaum J; Ausias N; Barlesi F; Montana M
J Clin Pharm Ther; 2018 Jun; 43(3):320-326. PubMed ID: 29092096
[TBL] [Abstract][Full Text] [Related]
12. The Role of Skin Tests in the Prevention and Diagnosis of Hypersensitivity Reactions to Platinum Agents in Gynecological Cancer: A Single-Center Italian Retrospective Study.
Puxeddu I; Petrelli F; Guerrieri ME; Cosio S; Del Corso I; Rocchi V; Manca ML; Migliorini P; Gadducci A
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771629
[TBL] [Abstract][Full Text] [Related]
13. BAT in the Diagnosis of Drug Allergy: a Novel Tool in Clinical Daily Practice?
Campos L; Galvão VR; Kalil J; Castells M; Giavina-Bianchi P
Curr Allergy Asthma Rep; 2019 Mar; 19(4):20. PubMed ID: 30859323
[TBL] [Abstract][Full Text] [Related]
14. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
Wang AL; Patil SU; Long AA; Banerji A
Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
[TBL] [Abstract][Full Text] [Related]
15. Specific IgE and Basophil Activation Test by Microarray: A Promising Tool for Diagnosis of Platinum Compound Hypersensitivity Reactions.
Fernández-Lozano C; Rita CG; Barra-Castro A; de la Hoz Caballer B; Roldán E; Pueyo López C; Martinez-Botas J; Berges-Gimeno MP
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612700
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity Reactions to Platinum Agents and Taxanes.
Tsao LR; Young FD; Otani IM; Castells MC
Clin Rev Allergy Immunol; 2022 Jun; 62(3):432-448. PubMed ID: 34338975
[TBL] [Abstract][Full Text] [Related]
17. The Contribution of the Basophil Activation Test to the Diagnosis of Hypersensitivity Reactions to Oxaliplatin.
Ornelas C; Caiado J; Campos Melo A; Pereira Barbosa M; Castells MC; Pereira Dos Santos MC
Int Arch Allergy Immunol; 2018; 177(3):274-280. PubMed ID: 30041169
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.
Leguy-Seguin V; Jolimoy G; Coudert B; Pernot C; Dalac S; Vabres P; Collet E
J Allergy Clin Immunol; 2007 Mar; 119(3):726-30. PubMed ID: 17258305
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.
Enrique E; Malek T; Castelló JV; de Mateo JA
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):86. PubMed ID: 18254488
[No Abstract] [Full Text] [Related]
20. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
